You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 19 No. 6, December 1968 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (42)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Development of Myelin in Inherited Disorders of Amino Acid Metabolism

A Biochemical Investigation

Arthur L. Prensky, MD; Sheila Carr, AB; Hugo W. Moser, MD

Arch Neurol. 1968;19(6):552-558.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN 1950, Alvord et al1 first suggested that the principal neuropathological feature of phenylketonuria (PKU) was a delay in the development of myelin. Subsequently, other investigators described areas of pallor in sections of central white matter stained for myelin and retarded myelination of the long tracts.2,3 Similar abnormalities were found in maple syrup urine disease (MSUD).4-6 Biochemical investigations of the cerebral white matter of patients with these diseases have also indicated that myelin was accumulating at a slower rate than that found in normal brains. In both PKU and MSUD, the water content of cerebral white matter was increased and the lipid content reduced.7-10 The reduction of cerebrosides exceeded that of other lipid classes,9-11 which is to be expected, since the accumulation of this lipid most closely parallels the formation of normal myelin.12

While biochemical studies of this type confirmed prior histological observations, . . . [Full Text PDF of this Article]


Author Affiliations

Boston

From the Department of Neurology, Harvard Medical School, Cambridge, Mass, the Joseph P. Kennedy, Jr., Memorial Laboratories and the Neurology Service at the Massachusetts General Hospital, Boston, and the Walter E. Fernald State School, Waltham, Mass. Dr. Prensky is currently at the St. Louis Children's Hospital, St. Louis.


Footnotes

Submitted for publication May 25, 1968; accepted Aug 5.

Reprint requests to Massachusetts General Hospital, Boston 02114 (Dr. Moser).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.